Summary & Overview
HCPCS J1010: Injection of Methylprednisolone Acetate, 1 mg
HCPCS Level II code J1010 denotes the injection of methylprednisolone acetate, 1 mg, a commonly used corticosteroid preparation for anti-inflammatory and immunosuppressive indications. Nationally, accurate reporting of injectable drug codes like J1010 supports claims processing, drug utilization tracking, and consistent payment for outpatient procedures. This code matters for clinics, specialty practices, and ambulatory care sites that administer corticosteroid injections.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for this injectable medication, typical sites of service where J1010 is billed, and the role of the code in outpatient drug administration reporting. The publication also presents benchmarking and payment context where available, summarizes relevant policy updates affecting injectable drug billing, and clarifies coding considerations for service lines that commonly use corticosteroid injections.
The content is intended for billing professionals, practice managers, and policy analysts seeking a national perspective on coding and billing for methylprednisolone acetate injections and how J1010 fits into outpatient drug administration workflows.
Billing Code Overview
HCPCS Level II code J1010 represents an injection of methylprednisolone acetate, 1 mg. This code is used to report the administration of the corticosteroid preparation methylprednisolone acetate in a quantified dose of 1 mg.
Service type: Drug administration / injectable medication
Typical site of service: Outpatient clinic, physician office, ambulatory surgical center, or other outpatient settings where injectable corticosteroids are administered
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 62-year-old female with a history of osteoarthritis of the right knee presents to an orthopedic clinic with worsening joint pain and limited range of motion despite oral NSAIDs and physical therapy. The physician recommends an intra-articular corticosteroid injection containing methylprednisolone acetate to reduce inflammation and provide symptomatic relief. The clinical workflow includes consent, allergy and anticoagulation review, aseptic preparation of the injection site, optional local anesthetic, administration of J1010 (methylprednisolone acetate) into the affected joint under palpation or image guidance as clinically indicated, post-procedure observation for immediate adverse reactions, and documentation of the medication lot number, dosage, route, site, and patient response. Typical sites of service are ambulatory clinic/office, outpatient procedure suite, or emergency department when indicated. This service is commonly performed by orthopedic surgeons, sports medicine specialists, rheumatologists, or pain management physicians for inflammatory or degenerative joint conditions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable E/M service by the same physician on the same day of procedure | Use when a distinct evaluation and management visit is performed on the same day as the injection |